PMID: 38099Jan 1, 1979

Pharmacological activity of N-basic substituted derivatives of 1,3-dimethylxanthine

Eksperimentalna meditsina i morfologiia
G Iovcheva, D Staneva-Stoĭcheva

Abstract

The authors carried out studies on cats, guinea pigs, rats and mice, using isolated smooth muscle organs (bronchi, ileum of guinea pig), and examined bronchodilatating, diuretic, antihistaminic action and acute toxiticy of three N-basic substituted derivatives of 1,3-dimethiylxanthine (theophyline) namely: 7-bis-(2-hydroximethyl)-amino-ethyl theophyline under the form of a base (compound G111, tartarate (G112) and nicotinate (G113). The studies were performed in comparison with theophyline. It was found that the substance G113 had a considerable bronchodilatating effect, surpassing in strength and velocity that of theophyline. The examined substances had antihistaminic effect of G113 as the antihistaminic effect of G113 surpassed that of theophyline under experimental conditions in vivo. It was established that all three compounds manifested diuretic activity close to that of theophyline. The derivatives of theophyline, examined by us, had considerably lower toxicity (7,17, resp. 8 times) than that of theophyline. On the basis of the experimental results and some advantages of the examined compounds (good solubility, low toxicity) perspectives are seen for their eventual clinical trial as bronchodilatating and diuretic drugs.

Related Concepts

Derivatives
Cavia
Ileum
Broncholytic Effect
Smooth Muscle
Antihistamine [EPC]
Bronchi
Organ
Antihistamines, Classical
Diuretic Effect

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.